Solis Partners, a leading commercial solar energy provider, has completed the installation of a roof-mounted solar photovoltaic system for Bristol-Myers Squibb, a premier biopharmaceutical company based in New York City that discovers, develops and delivers innovative medicines for treating serious diseases and is a recognized leader in environmental stewardship.
The 777.14-kW system consists of 3,172 panels that span the entirety of the 106,500-square-foot parking structure at the company’s campus in Hopewell Township, N.J.
“It was really rewarding to partner with Bristol-Myers Squibb on this solar installation that will be owned and operated under a full service Power Purchase Agreement,” said Jamie Hahn, co-founder and managing director of Solis Partners. “Reducing the company’s environmental footprint with onsite solar power generation provides a cost-effective path to sustainability. Bristol-Myers is once again demonstrating their commitment to environmental leadership.”
In the first year of operation, the system is expected to produce approximately 965,000 kilowatt-hours of clean energy to the Bristol-Myers Squibb campus. Over the life of the system, this will equate to the reduction of more than 9,800 metric tons of CO2 gas emissions – roughly equivalent to the impact of removing 2,050 cars from the roads.
— Solar Builder magazine
Leave a Reply
You must be logged in to post a comment.